Patients with different lung cancers show normal expression of fra(3)(p14.2) in aphidicolin-treated lymphocyte cultures
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 43 (1) , 95-101
- https://doi.org/10.1016/0165-4608(89)90132-5
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Editorial: The fragile site hypothesis of cancerCancer Genetics and Cytogenetics, 1988
- Loss of common 3p14 fragile site expression in renal cell carcinoma with deletion breakpoint at 3p14Cancer Genetics and Cytogenetics, 1988
- Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(FRA3B) in lymphocytesCancer Genetics and Cytogenetics, 1988
- Of fragile sites and cancer chromosome breakpointsCancer Genetics and Cytogenetics, 1988
- Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancerNature, 1987
- Loss of heterozygosity of chromosome 3p markers in small-cell lung cancerNature, 1987
- Common fragile sites: Their prevalence in subjects with constitutional and acquired chromosomal instabilityAmerican Journal of Medical Genetics, 1987
- Nonrandom chromosome alterations in rhabdomyosarcomaCancer Genetics and Cytogenetics, 1985
- Del(3)(p13) in B-prolymphocytic leukemia—A new nonrandom chromosomal aberration possibly related to the c-ras oncogeneCancer Genetics and Cytogenetics, 1985
- Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-αNature, 1978